Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

5188 Results Found

FDA seeks feedback on measuring AI-enabled medical device performance

The Food and Drug Administration today issued a request for

Administration announces agreement with Pfizer to lower drug costs

President Trump today announced the first agreement with a major pharmaceutical company, Pfizer, to bring American drug prices in line with the lowest paid by other developed nations — wh

AHA says HRSA vastly underestimates costs 340B Rebate Pilot Program will inflict on hospitals, urges agency to delay implementation

The anticipated burdens on hospitals to comply with the Health Resources and Services Administration’s 340B Rebate Pilot Program far exceed the agency’s estimates, and HRSA should delay the program

OSTP seeks comment on laws, regulations hindering AI development and adoption

The Office of Science and Technology Policy issued a request for information Sept. 26 seeking feedback on federal regulations that hinder AI development, deployment, or adoption.

AHA urges DHS to maintain current policy for physicians in U.S. with J-1 visas 

The AHA urged the Department of Homeland Security today to maintain “duration of status” as an authorized period of stay for the nearly 17,000 physicians nationwide with J-1 visas who are participating in residency and fellowship programs.

AHA urges administration to make health care personnel exempt from H-1B visa changes 

The AHA Sept. 29 asked the Trump administration to provide exemptions for health care personnel from the proclamation issued Sept. 19 announcing changes to the H-1B visa program.

AHA provides recommendations to HHS, CMS for insurers to adhere to prior authorization pledge 

The AHA Sept. 29 sent recommendations to the Department of Health and Human Services and the Centers for Medicare & Medicaid Services to help ensure insurance plans adhere to the agencies’ health insurer pledge to reform prior authorization processes.

CMS says premiums, enrollment for MA and Part D to slightly decline for 2026 

The Centers for Medicare & Medicaid Services announced Sept. 26 that average premiums for Medicare Advantage and Part D would decline slightly in 2026.

President announces new tariffs, including for certain pharmaceuticals, set to begin Oct. 1 

President Trump, late Sept. 25, announced that starting Oct. 1, the U.S. will impose a 100% tariff on any branded or patented pharmaceutical product, unless a company is building its pharmaceutical manufacturing plant in America.